Biodexa Pharmaceuticals Plc (BDRX)

NASDAQ: BDRX · Real-Time Price · USD

2.433

-0.057 (-2.28%)

Jul 13, 2026, 10:01 AM EDT - Market open

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pipeline Research and Development (Pipeline R&D)			381.00K	699.00K	578.00K	343.00K	674.00K
Pipeline Research and Development (Pipeline R&D) Growth			-45.49%	20.93%	68.51%	-49.11%	-65.22%
Total			381.00K	699.00K	578.00K	343.00K	674.00K
Total Growth			-45.49%	20.93%	68.51%	-49.11%	-65.22%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Belgium			381.00K	699.00K	578.00K	114.00K	-
Belgium Growth			-45.49%	20.93%	407.02%	-	-
United Kingdom			-	-	-	4.00K	197.00K
United Kingdom Growth			-	-	-	-97.97%	32.21%
Rest of The World			-	-	-	62.00K	60.00K
Rest of The World Growth			-	-	-	3.33%	-
Rest of Europe			-	-	-	-	55.00K
Total			381.00K	699.00K	578.00K	180.00K	312.00K
Total Growth			-45.49%	20.93%	221.11%	-42.31%	109.40%